C12N 2720/12322
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2720/12322 (New viral proteins or individual genes, new structural or functional aspects of) appears on 97 US grants and 73 published applications in this corpus.
Search patents in C12N- Granted patents
- 97
- Published applications
- 73
- Assignees
- 87
- Inventors
- 265
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 12 | 0 |
| 1999 | 9 | 0 |
| 2000 | 9 | 0 |
| 2001 | 6 | 0 |
| 2002 | 1 | 2 |
| 2003 | 3 | 8 |
| 2004 | 5 | 4 |
| 2005 | 2 | 4 |
| 2006 | 1 | 2 |
| 2007 | 2 | 2 |
| 2008 | 0 | 5 |
| 2009 | 1 | 2 |
| 2010 | 3 | 4 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 2 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 5 |
| 2019 | 1 | 1 |
| 2020 | 3 | 1 |
| 2021 | 0 | 3 |
| 2022 | 1 | 6 |
| 2023 | 0 | 0 |
| 2024 | 3 | 4 |
| 2025 | 2 | 6 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing artificial recombinant RNA virus stably retaining foreign gene20 May 2025US 12,305,192 B2Osaka University
- Porcine rotavirus13 May 2025US 12,297,459 B2Intervet Inc.
- Recombinant rotavirus expression system and recombinant rotaviruses24 Dec 2024US 12,173,032 B2The Trustees of Indiana University
- Control of replication and transcription of self-replicating RNA in response to small molecules12 Nov 2024US 12,139,721 B2Massachusetts Institute of Technology
- Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine9 Apr 2024US 11,952,400 B2Tecon Biopharmaceutical Co., Ltd.
- Trigger-inducible mrna circularization23 Jul 2026US 2026/0209789 A1Westlake University
- Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same9 Jul 2026US 2026/0191949 A1Children's Hospital Medical Center
- Rotavirus b virus-like-particle compostions and antibody assays11 Jun 2026US 2026/0158131 A1University of Kentucky Research Foundation
- Method for preparing reassortant rotavirus13 Nov 2025US 2025/0346867 A1
- Rotavirus vaccines4 Sep 2025US 2025/0276053 A1VST LLC dba Medgene
Most cited
By later US patents
- Oral vaccines118US 4,920,209 AAmerican Home Products Corporation · 1990
- Recombinant flagellin vaccines92US 6,130,082 AAmerican Cyanamid Company · 2000
- Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence86US 5,223,424 APrutech Research And Development · 1993
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system81US 5,891,676 ABaylor College of Medicine · 1999
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system78US 5,843,733 ABaylor College of Medicine · 1998